Applications of Deep Learning in Tissue-based Biomarker Analysis for Drug Development
26 Jun 2020
In this webinar you will gain a deeper understanding of what deep learning is, how it works in reproducing pathologist’s expertise in the biomarker analysis of histopathological samples and why this is technology is the key to unlocking the future for biomarker discovery in drug development.
Hosting will be our CEO, Sylvain Berlemont, Ph.D, and David Guet, our scientific partnership manager. Webinar will go live at 3pm (CEST)/9am (EDT) on 17th of June. Join us and submit your questions!
Watch the replay below:
Keen Eye Webinar: The AI Platform for Tissue Insights